Inactive Instrument

Highlights KetamineOne Capital Deutsche Boerse AG

Equities

MY00

CA4925531028

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cardinal Group Companies LLC entered into an agreement to acquire KGK Science Inc. from Wellbeing Digital Sciences Inc. for $2 million.	23-06-15	CI
Wellbeing Digital Sciences Inc.'s Wholly Owned Subsidiary KGK Sciences Inc Begins Recruitment in First-Of-Its-Kind Health Canada Approved Psilocybin Trial	23-04-18	CI
Nova Mentis Enters into Research Services Contract with KGK Science for Phase II A Clinical Trial	22-11-17	CI
Wellbeing Digital Signs LOI Manage Additional Clinics	22-10-04	CI
Wellbeing Digital Sciences Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	22-09-13	CI
Wellbeing Digital Sciences Inc. Reports Earnings Results for the Fourth Quarter Ended July 31, 2022	22-09-13	CI
Wellbeing Digital Seeks Acquisitions	22-08-18	CI
Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (JointAlive(R)) Supplementation in Treating OA	22-06-16	CI
Wellbeing Digital Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-14	CI
Pathway Health Corp. (TSXV : PHC) entered into a memorandum of understanding to acquire Assets of Wellbeing Digital Sciences Inc and IRP Health Ltd	22-04-20	CI
Wellbeing Digital Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	22-03-16	CI
Wellbeing Digital Sciences Inc Delivers its First IV Ketamine Treatment Under the Inpatient KITE Program	22-02-15	CI
Ketamine One Becomes Exclusive Ketamine Treatment Provider to Victoria Wellness	22-01-17	CI
Ketamine One Reports Strong 1Q22 Financial Results	21-12-16	AQ
KetamineOne Capital Limited Reports Earnings Results for the First Quarter Ended October 31, 2021	21-12-15	CI
Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year	21-12-13	AQ
KetamineOne Capital Limited Reports Earnings Results for the Full Year Ended July 31, 2021	21-12-13	CI
Myconic Capital Corp. cancelled the acquisition of NY Ketamine Medical Practice PLLC.	21-12-12	CI
Ketamineone Adds Seattle Location to Us Clinical Network	21-12-08	CI
KetamineOne Capital Limited Enters into A Collaborative Partnership with Cognetivity Neurosciences Ltd. to Study and Develop Assessments for Depression and Post-Traumatic Stress Disorder	21-12-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights KetamineOne Capital Deutsche Boerse AG

Equities

MY00

CA4925531028

Highlights

Filters